pharmaphorum

SEPTEMBER 9, 2020

Everything the 100,000 Genomes Project does has to be rubber-stamped by the patients”. At the time, the Sanger Institute was working on the Deciphering Developmental Disorders study (DDD), which looked at the approximately 1-2% of the genome that is responsible for making proteins in patients with rare diseases.

Genome 86

Genome Genomics Genetics Genome Project 86

pharmaphorum

SEPTEMBER 9, 2020

Everything the 100,000 Genomes Project does has to be rubber-stamped by the patients”. At the time, the Sanger Institute was working on the Deciphering Developmental Disorders study (DDD), which looked at the approximately 1-2% of the genome that is responsible for making proteins in patients with rare diseases.

Genome 73

Genome Genomics Genetics Genome Project 73

Drug Discovery World

MARCH 6, 2024

To find new ways of diagnosing and treating complex diseases we first must understand the mechanisms underpinning their key pathological drivers, how these relate to different patient subgroups, and which drugs might be useful in ameliorating their effects – this is the basis of precision neuroscience.

Genome 64

Genome Genomics Clinical Trials Clinical Trials 64